JDReevesMD

Internal Medicine • Defiance, OH

Hospital Medicine/Hospitalist

Physician

Join to view full profile

Are you Dr. Reeves?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 51 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1400 E 2nd St
Defiance, OH 43512
Phone+1 419-784-1414

Fax+1 419-783-3014
Is this information wrong?

Summary

Dr. J Reeves, MD is an internist in Defiance, Ohio. He is currently licensed to practice medicine in Ohio and Michigan. He is affiliated with Mercy Health - Defiance Hospital and ProMedica Defiance Regional Hospital.

Education & Training

Eastern Virginia Medical SchoolResidency, Internal Medicine, 1993 - 1994
Eastern Virginia Medical SchoolResidency, Urology, 1992 - 1993
Ascension St John HospitalResidency, Surgery, 1990 - 1992
Kettering Health Network/Kettering Medical CenterResidency, Internal Medicine, 1988 - 1990
Wright State University Boonshoft School of MedicineClass of 1988

Certifications & Licensure

OH State Medical License 1989 - 2026
MI State Medical License 1990 - 1992

Publications & Presentations

PubMed

High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.
Nedellec R, Herbeck JT, Hunt PW, Deeks SG, Mullins JI, Anton ED, Reeves JD, Mosier DE> ;AIDS Res. Hum. Retroviruses. 2016-10-12
Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 inf...
Barnard RJO, McHale CM, Newhard W, Cheney CA, Graham DJ, Himmelberger AL, Strizki J, Hwang PMT, Rivera AA, Reeves JD, Nickle D, Dinubile MJ, Hazuda DJ, Mobashery N> ;Virology. 2013-09-01
Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
O'Connell O, Repik A, Reeves JD, Gonzalez-Perez MP, Quitadamo B, Anton ED, Duenas-Decamp M, Peters P, Lin R, Zolla-Pazner S, Corti D, Wallace A, Wang S, Kong X, Lu S, ...> ;J. Virol.. 2013-01-01
Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.
Green TN, Archary M, Gordon ML, Padayachi N, Lie Y, Anton ED, Reeves JD, Grobler A, Bobat R, Coovadia H, Ndung'u T> ;AIDS Res. Hum. Retroviruses. 2012-04-01
DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions.
Pöhlmann, S., Leslie, G. J., Edwards, T. G., Macfarlan, T., Reeves, J. D., Hiebenthal-Millow, K., Kirchhoff, F., Baribaud, F., Doms, R. W.> ;J Virol. 2001 Nov
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat.
Ghezzi, S., Noonan, D.M., Aluigi, M.G., Vallanti, G., Cota, M., Benelli, R., Morini, M., Reeves, J.D., Vicenzi, E., Poli, G., Albini, A.> ;Biochem Biophys Res Commun. 2000 Apr 21
Chemokine inhibition of HIV infection.
Reeves, J.D., Simmons, G.> ;Methods Mol Biol. 2000
Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and ...
Reeves, J.D., Hibbitts, S., Simmons, G., McKnight, A., Azevedo-Pereira, J.M., Moniz-Pereira, J., Clapham, P.R.> ;J Virol. 1999 Sep
Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1.
Hibbitts, S., Reeves, J.D., Simmons, G., Gray, P.W., Epstein, L.G., Schols, D., de Clercq, E., Wells, T.N., Proudfoot, A.E., Clapham, P.R.> ;AIDS Res Hum Retroviruses. 1999 Jul 20
CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages.
Simmons, G., Reeves, J.D., McKnight, A., Dejucq, N., Hibbitts, S., Power, C.A., Aarons, E., Schols, D., De Clercq, E., Proudfoot, A.E., Clapham, P.R.> ;J Virol. 1998 Oct
25 citations
The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2
Jacqueline D. Reeves, Nikolaus Heveker, Anne Brelot, Marc Alizon, Paul R. Clapham, Laurent Picard> ;The Journal of General Virology. 1998 Jul 1
A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.
McKnight, A., Dittmar, M.T., Moniz-Periera, J., Ariyoshi, K., Reeves, J.D., Hibbitts, S., Whitby, D., Aarons, E., Proudfoot, A.E., Whittle, H., Clapham, P.R.> ;J Virol. 1998 May
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.
Boshoff, C., Endo, Y., Collins, P.D., Takeuchi, Y., Reeves, J.D., Schweickart, V.L., Siani, M.A., Sasaki, T., Williams, T.J., Gray, P.W., Moore, P.S., Chang, Y., Weiss...> ;Science. 1997 Oct 10
CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry.
Potempa, S., Picard, L., Reeves, J.D., Wilkinson, D., Weiss, R.A., Talbot, S.J.> ;J Virol. 1997 Jun
CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry.
Reeves, J.D., McKnight, A., Potempa, S., Simmons, G., Gray, P.W., Power, C.A., Wells, T., Weiss, R.A., Talbot, S.J.> ;Virology. 1997 Apr 28
Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization. Modulation by continuous sedation. Multicenter Study of Perioperative Is...
Plunkett, J.J., Reeves, J.D., Ngo, L., Bellows, W., Shafer, S.L., Roach, G., Howse, J., Herskowitz, A., Mangano, D.T.> ;Anesthesiology. 1997 Apr
73 citations
The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold ...
Jacqueline D. Reeves, Thomas F. Schulz> ;Journal of Virology. 1997 Feb 1
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.
Simmons, G., Wilkinson, D., Reeves, J.D., Dittmar, M.T., Beddows, S., Weber, J., Carnegie, G., Desselberger, U., Gray, P.W., Weiss, R.A., Clapham, P.R.> ;J Virol. 1996 Dec
Cardiovascular responses during sedation after coronary revascularization. Incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam. In...
Wahr JA, Plunkett JJ, Ramsay JG, Reeves J, Jain U, Ley C, Wilson R, Mangano DT> ;Anesthesiology. 1996-06-01
Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage.
Schulz TF, Reeves JD, Hoad JG, Tailor C, Stephens P, Clements G, Ortlepp S, Page KA, Moore JP, Weiss RA> ;AIDS Res. Hum. Retroviruses. 1993-02-01
11 citations
Tumours of the limbic and paralimbic system.
M G Yaşargil, J D Reeves> ;Acta Neurochirurgica. 1992 Jan 1
50 citations
Slit ventricle syndrome in children: Clinical presentation and treatment
Edward C. Benzel, J. D. Reeves, L. Kesterson, Th. A. Hadden> ;Acta Neurochirurgica. 1992 Jan 1
Uric acid protects membranes and linolenic acid from ozone-induced oxidation.
Meadows J, Smith RC, Reeves J> ;Biochem. Biophys. Res. Commun.. 1986-05-29
The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group.
Helman, J. D., Leung, J. M., Bellows, W. H., Pineda, N., Roach, G. W., Reeves, J. D., Howse, J., McEnany, M. T., Mangano, D. T.> ;Anesthesiology. 1992 Jul
Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options.
Singh, A., Sunpath, H., Green, T. N., Padayachi, N., Hiramen, K., Lie, Y., Anton, E. D., Murphy, R., Reeves, J. D., Kuritzkes, D. R., Ndung'u, T.> ;J Acquir Immune Defic Syndr. 2011 Nov 1
Join now to see all

Hospital Affiliations

ProMedica Defiance Regional HospitalDefiance, Ohio
Mercy Health - Defiance HospitalDefiance, Ohio